Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Katharine J Herbert

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Chemico-Biological Interactions|May 29, 2012
Modulation of arsenic-induced epidermal growth factor receptor pathway signalling by resveratrolKatharine J Herbert, Elizabeth T Snow
Toxicology and Applied Pharmacology|April 15, 2014
SIRT1 inhibition restores apoptotic sensitivity in p53-mutated human keratinocytesKatharine J Herbert, Anthony L Cook, Elizabeth T Snow
Journal of Dermatological Science|February 20, 2014
SIRT1 modulates miRNA processing defects in p53-mutated human keratinocytesKatharine J Herbert, Anthony L Cook, Elizabeth T Snow
Cell Death & Disease|October 26, 2018
T-LAK cell-originated protein kinase (TOPK): an emerging target for cancer-specific therapeuticsKatharine J Herbert, Thomas M Ashton, Remko Prevo, et al.
Toxicology and Applied Pharmacology|October 5, 2014
Arsenic exposure disrupts epigenetic regulation of SIRT1 in human keratinocytesKatharine J Herbert, Adele Holloway, Anthony L Cook, et al.
Cell Death and Differentiation|November 10, 2020
Targeting TOPK sensitises tumour cells to radiation-induced damage by enhancing replication stressKatharine J Herbert, Rathi Puliyadi, Remko Prevo, et al.
Cell Cycle (Georgetown, Tex.)|July 27, 2018
CDK1 inhibition sensitizes normal cells to DNA damage in a cell cycle dependent mannerRemko Prevo, Giacomo Pirovano, Rathi Puliyadi, et al.
British Journal of Cancer|May 29, 2025
Sequential ATR and PARP inhibition overcomes acquired DNA damaging agent resistance in pancreatic ductal adenocarcinomaKatharine J Herbert, Rosie Upstill-Goddard, Stephan B Dreyer, et al.
British Journal of Cancer|July 6, 2017
TOPK modulates tumour-specific radiosensitivity and correlates with recurrence after prostate radiotherapyGiacomo Pirovano, Thomas M Ashton, Katharine J Herbert, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Chemico-Biological Interactions|May 29, 2012
Modulation of arsenic-induced epidermal growth factor receptor pathway signalling by resveratrolKatharine J Herbert, Elizabeth T Snow
Toxicology and Applied Pharmacology|April 15, 2014
SIRT1 inhibition restores apoptotic sensitivity in p53-mutated human keratinocytesKatharine J Herbert, Anthony L Cook, Elizabeth T Snow
Journal of Dermatological Science|February 20, 2014
SIRT1 modulates miRNA processing defects in p53-mutated human keratinocytesKatharine J Herbert, Anthony L Cook, Elizabeth T Snow
Cell Death & Disease|October 26, 2018
T-LAK cell-originated protein kinase (TOPK): an emerging target for cancer-specific therapeuticsKatharine J Herbert, Thomas M Ashton, Remko Prevo, et al.
Toxicology and Applied Pharmacology|October 5, 2014
Arsenic exposure disrupts epigenetic regulation of SIRT1 in human keratinocytesKatharine J Herbert, Adele Holloway, Anthony L Cook, et al.
Cell Death and Differentiation|November 10, 2020
Targeting TOPK sensitises tumour cells to radiation-induced damage by enhancing replication stressKatharine J Herbert, Rathi Puliyadi, Remko Prevo, et al.
Cell Cycle (Georgetown, Tex.)|July 27, 2018
CDK1 inhibition sensitizes normal cells to DNA damage in a cell cycle dependent mannerRemko Prevo, Giacomo Pirovano, Rathi Puliyadi, et al.
British Journal of Cancer|May 29, 2025
Sequential ATR and PARP inhibition overcomes acquired DNA damaging agent resistance in pancreatic ductal adenocarcinomaKatharine J Herbert, Rosie Upstill-Goddard, Stephan B Dreyer, et al.
British Journal of Cancer|July 6, 2017
TOPK modulates tumour-specific radiosensitivity and correlates with recurrence after prostate radiotherapyGiacomo Pirovano, Thomas M Ashton, Katharine J Herbert, et al.
Pageof 1